<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01627509</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-10-7894-JI-CTIL</org_study_id>
    <nct_id>NCT01627509</nct_id>
  </id_info>
  <brief_title>Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.</brief_title>
  <official_title>Comparison of Modern Premixed Insulin and Basal-Bolus Regimens on Blood Glucose Control Using CGMS Device in Optimally-controlled Subjects With DM2.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intensive Insulin Therapy (IIT) may be given in Type 2 Diabetes (T2DM) in two different ways
      :

        -  as Basal/bolus therapy (B/B) in four-five injections per day .

        -  as Modern Premixed Insulins( MPI's) three times per day . The better diabetes control is
           achieved, the more likely patient would suffer from hypoglycemic episodes. We propose
           that the probability of hypoglycemia and its severity has no difference in two main
           insulin therapy schemes mentioned above.

      The objective of the study is to compare the incidence of hypoglycemia and its severity in
      well-controlled ( HBA1C less than 7%) diabetic individuals treated by two different regimens,
      through analysis of data received by Continuous Glucose Monitoring (CGM, Free Style
      Navigator).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Diabetes Mellitus 2 Type</condition>
  <eligibility>
    <study_pop>
      <textblock>
        40 Subjects with 1 year and more of T2DM history , with two consistent HbA1C values of 7%
        or less - according to the blood tests within last six months.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Major Inclusion Criteria:

          -  Diabetes Mellitus Type 2 diagnosis confirmed by endocrinologist.

          -  Diabetes Mellitus Type 2 history of one year at least.

          -  HAb1C &lt; 7% and less

          -  Age 18-80 yrs

          -  Normal Liver function tests

        Major Exclusion Criteria:

          -  History of substance use

          -  Pregnancy or breastfeeding mothers

          -  Abnormal liver or kidney functional tests

          -  Type 1 Diabetes or LADA

          -  any active disease ( like viral) at the period of investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jacob Ilani, Dr.</last_name>
    <phone>+97235303103</phone>
    <email>Jacob.Ilany2@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shmuel Levit, Dr.</last_name>
    <phone>+972508805375</phone>
    <email>Shlevit@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Institute of Endocrinology, Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <state>Gush Dan</state>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacob Ilani, DR.</last_name>
      <phone>+97235303103</phone>
      <email>Jacob.Ilany2@sheba.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Shmuel Levit, DR.</last_name>
      <phone>+972508805375</phone>
      <email>shlevit@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jacob Ilani, DR.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shmuel Levit, DR.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2012</study_first_submitted>
  <study_first_submitted_qc>June 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2012</study_first_posted>
  <last_update_submitted>June 21, 2012</last_update_submitted>
  <last_update_submitted_qc>June 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>continuous glucose monitoring system</keyword>
  <keyword>hypoglycemia</keyword>
  <keyword>insulin regimen</keyword>
  <keyword>basal bolus therapy</keyword>
  <keyword>modern premixed insulin</keyword>
  <keyword>diabetes control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

